Depression medication can cause gastrointestinal bleedings

A recent research presented at Digestive Disease Week 2005, antidepressants have shown to cause// gastrointestinal bleedings. Clinical depression, also known as unipolar depression, is often treated with antidepressant drugs like selective serotonin reuptake inhibitors (SSRIs) by physicians. ...

FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia

...weats, fevers, and decreased appetite and weight loss. Bone marrow infiltration leads to a lack of healthy blood cells, thus causing susceptibility to bleedings and weakening of the immune system, exposing the patient to a higher risk of infection. Additional Information About Campath Campath is indicated as...

Hope for Marburg treatment: vaccine successful in primates

...t. The symptoms begin with severe headaches and feeling of severe unwell. Patients develop severe hemorrhagic manifestations and often turn fatal with bleedings from various locations. There is no specific treatment currently available. In another trial a few years ago, researchers from National Institute...

bleedings in Medical Technology

Positive Aggrastat Results Featured in the Journal of the American College of Cardiology

...al Infarction Study group (TIMI). Most major bleeding associated with AGGRASTATR occurs at the arterial access site for cardiac catheterization. Fatal bleedings have been reported. AGGRASTATR should be used with caution in patients with platelet count less than 150,000/mm3, in patients with hemorrhagic retinop...

bleedings in Biological Technology

FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia

...weats, fevers, and decreased appetite and weight loss. Bone marrow infiltration leads to a lack of healthy blood cells, thus causing susceptibility to bleedings and weakening of the immune system, exposing the patient to a higher risk of infection. Additional Information About Campath Campath is indicated as...

ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402

...ause it only partially inhibits factor VIII activity even when administrated in very high doses. This may potentially decrease the risk of undesirable bleedings and the need for monitoring, which are the main concerns associated with anticoagulants currently on the market. The trial, performed in Denmark, was...